- Home
- PRKS vs XENE Comparison
PRKS vs XENE Comparison
Compare PRKS & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRKS
- XENE
- Stock Information
- Founded
- PRKS 1959
- XENE 1996
- Country
- PRKS United States
- XENE Canada
- Employees
- PRKS N/A
- XENE N/A
- Industry
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- PRKS Health Care
- XENE Health Care
- Exchange
- PRKS Nasdaq
- XENE Nasdaq
- Market Cap
- PRKS 2.8B
- XENE 3.3B
- IPO Year
- PRKS 2013
- XENE 2014
- Fundamental
- Price
- PRKS $45.64
- XENE $35.18
- Analyst Decision
- PRKS Buy
- XENE Strong Buy
- Analyst Count
- PRKS 9
- XENE 7
- Target Price
- PRKS $61.67
- XENE $57.00
- AVG Volume (30 Days)
- PRKS 1.1M
- XENE 513.4K
- Earning Date
- PRKS 05-07-2025
- XENE 02-27-2025
- Dividend Yield
- PRKS N/A
- XENE N/A
- EPS Growth
- PRKS 4.41
- XENE N/A
- EPS
- PRKS 3.79
- XENE N/A
- Revenue
- PRKS $1,725,301,000.00
- XENE N/A
- Revenue This Year
- PRKS $3.29
- XENE N/A
- Revenue Next Year
- PRKS $2.81
- XENE $826.46
- P/E Ratio
- PRKS $12.37
- XENE N/A
- Revenue Growth
- PRKS N/A
- XENE N/A
- 52 Week Low
- PRKS $44.72
- XENE $33.27
- 52 Week High
- PRKS $60.83
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- PRKS 30.93
- XENE 38.32
- Support Level
- PRKS $48.03
- XENE $33.82
- Resistance Level
- PRKS $50.30
- XENE $38.08
- Average True Range (ATR)
- PRKS 2.42
- XENE 2.02
- MACD
- PRKS -0.52
- XENE -0.23
- Stochastic Oscillator
- PRKS 3.88
- XENE 28.38
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc operates in the United States leisure industry. Its core business is the operation of theme parks and such entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove and Sesame Place. The company generates majority of its revenue from selling admission tickets for its theme parks.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.